Ameriprise Financial Inc Allogene Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 177,113 shares of ALLO stock, worth $384,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares

177,113

Previous 338,045 47.61%

Holding current value

$384,335

Previous $787,000 37.1%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.08 - $3.5 $334,738 - $563,262	-160,932 Reduced 47.61%	177,113 $495,000
Q2 2024 Aug 14, 2024	BUY	$2.23 - $4.38 $332,281 - $652,641	149,005 Added 78.82%	338,045 $787,000
Q1 2024 May 15, 2024	SELL	$2.92 - $5.63 $3,664 - $7,065	-1,255 Reduced 0.66%	189,040 $845,000
Q4 2023 Feb 14, 2024	BUY	$2.28 - $3.5 $127,005 - $194,964	55,704 Added 41.39%	190,295 $610,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $5.96 $74,225 - $139,553	23,415 Added 21.06%	134,591 $426,000
Q2 2023 Aug 14, 2023	SELL	$4.53 - $6.74 $3.16 Million - $4.7 Million	-697,048 Reduced 86.24%	111,176 $552,000
Q1 2023 May 15, 2023	BUY	$4.92 - $8.21 $821,817 - $1.37 Million	167,036 Added 26.05%	808,224 $3.99 Million
Q4 2022 Feb 14, 2023	SELL	$5.62 - $11.11 $728,885 - $1.44 Million	-129,695 Reduced 16.82%	641,188 $4.03 Million
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $2.86 Million - $4.78 Million	-276,682 Reduced 26.41%	770,883 $8.31 Million
Q2 2022 Aug 15, 2022	BUY	$6.78 - $12.28 $264,616 - $479,276	39,029 Added 3.87%	1,047,565 $11.9 Million
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $2.25 Million - $4.49 Million	293,874 Added 41.12%	1,008,536 $9.19 Million
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $4.37 Million - $8.16 Million	332,832 Added 87.17%	714,662 $10.7 Million
Q3 2021 Nov 15, 2021	BUY	$21.01 - $27.64 $7.42 Million - $9.76 Million	353,249 Added 1235.96%	381,830 $9.81 Million
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $99,456 - $151,577	4,234 Added 17.39%	28,581 $745,000
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $127,067 - $192,251	-4,927 Reduced 16.83%	24,347 $859,000
Q4 2020 Feb 12, 2021	SELL	$25.24 - $43.45 $37,077 - $63,828	-1,469 Reduced 4.78%	29,274 $739,000
Q3 2020 Nov 16, 2020	SELL	$32.38 - $44.96 $121,522 - $168,734	-3,753 Reduced 10.88%	30,743 $1.16 Million
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $634,381 - $1.86 Million	34,496 New	34,496 $1.48 Million

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $312M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Allogene Therapeutics, Inc. Transaction History